Form D · Biotechnology
KeriCure Inc
Wesley Chapel, FL · CIK 0001555663
Offering snapshot reported Apr 28, 2014 · SEC filing
- Reported sold
- Yet to sell Offering amount: $2M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 28, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 10, 2013 | Amendment | $800,000 | $157,500vs Dec 4, 2012 | 12 | SEC filing |
| Dec 4, 2012 | Amendment | $642,500 | $332,500vs Aug 7, 2012 | 10 | SEC filing |
| Aug 7, 2012 | Initial | $310,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 4a5
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-216407
Source: Form D, filed Apr 28, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tami Brotherton | Executive |
| Vivian Lauderdale | Director |
| Daniel Mc Lain | Director |
| Kerriann Robyn Opp | Director, Executive |
| Jesus Manuel Rodriguez | Director |
| Edward Turos | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
26620 Easy St
Wesley Chapel, FL, 33544
Wesley Chapel, FL, 33544